Reata Pharmaceuticals (NASDAQ:RETA) Downgraded to Neutral at LADENBURG THALM/SH SH kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Citigroup cut shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, Marketbeat reports. Citigroup currently has $172.50 target price on the stock, up from their prior target price of $127.00. Other equities analysts have also recently issued reports about the […]
Reata Pharmaceuticals (NASDAQ:RETA) Downgraded to Neutral at Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA – Free Report) had its target price lifted by Robert W. Baird from $85.00 to $173.00 in a research note published on Monday morning, Marketbeat Ratings reports. Robert W. Baird currently has an outperform rating on the stock. RETA has been the topic of several other reports. StockNews.com initiated coverage on Reata […]
Reata Pharmaceuticals (NASDAQ:RETA – Get Free Report) was downgraded by equities research analysts at SVB Securities from an “outperform” rating to a “market perform” rating in a research report issued on Friday, FlyOnTheWall reports. Several other analysts have also commented on the stock. Stifel Nicolaus lowered shares of Reata Pharmaceuticals from a “buy” rating to […]